X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
immunohistochemistry (4) 4
index medicus (4) 4
carcinoma (3) 3
female (3) 3
lung neoplasms - metabolism (3) 3
lung neoplasms - pathology (3) 3
male (3) 3
middle aged (3) 3
pathology (3) 3
adenocarcinoma (2) 2
adenocarcinoma, papillary - genetics (2) 2
adenocarcinoma, papillary - pathology (2) 2
aged (2) 2
biopsy (2) 2
care and treatment (2) 2
cell proliferation - drug effects (2) 2
classification (2) 2
histology (2) 2
lung adenocarcinoma (2) 2
lung neoplasms - genetics (2) 2
medical research (2) 2
metastasis (2) 2
mutation (2) 2
neoplasm staging (2) 2
neovascularization, pathologic - drug therapy (2) 2
oncology (2) 2
papillary (2) 2
pathology and forensic medicine (2) 2
poor-prognosis (2) 2
tumors (2) 2
vascular endothelial growth factor (2) 2
vascular endothelial growth factor receptor-2 - antagonists & inhibitors (2) 2
adenocarcinoma, papillary - metabolism (1) 1
adenocarcinoma, papillary - mortality (1) 1
aerogeneous micropapillary pattern (1) 1
aerogenous micropapillary component (1) 1
amyloidosis - etiology (1) 1
amyloidosis - pathology (1) 1
amyloidosis - physiopathology (1) 1
angiogenesis (1) 1
animals (1) 1
anti-angiogenic therapy/strategy (1) 1
antiangiogenic therapy (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antitumor-activity (1) 1
apoptosis - drug effects (1) 1
ascites - pathology (1) 1
association (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - metabolism (1) 1
biopsy, large-core needle - methods (1) 1
bridge (1) 1
cancer (1) 1
cancer cells (1) 1
cancer patients (1) 1
cancer research (1) 1
carcinoma, small cell - blood supply (1) 1
carcinoma, small cell - drug therapy (1) 1
carcinoma, small cell - metabolism (1) 1
case report (1) 1
case studies (1) 1
cell line, tumor (1) 1
clinical research (1) 1
component (1) 1
cross-sectional studies (1) 1
diagnosis (1) 1
discriminate (1) 1
disease-free survival (1) 1
dose-response relationship, drug (1) 1
egfr (1) 1
endothelial growth-factor (1) 1
entorhinal cortex (1) 1
expression (1) 1
factor vegf (1) 1
factor-c (1) 1
fatal outcome (1) 1
features (1) 1
females (1) 1
gefitinib (1) 1
gene expression profiling (1) 1
genes, erbb-1 (1) 1
genes, erbb-1 - genetics (1) 1
glut-1 (1) 1
growth-factor receptor (1) 1
hamartoma - complications (1) 1
hamartoma - pathology (1) 1
health aspects (1) 1
hemangioma - complications (1) 1
hemangioma - pathology (1) 1
hippocampus (1) 1
human (1) 1
in situ nick-end labeling (1) 1
in vivo calcium imaging (1) 1
intelectin 1 (1) 1
island (1) 1
japan (1) 1
lenvatinib (1) 1
lung diseases - complications (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


MOLECULAR BRAIN, ISSN 1756-6606, 11/2019, Volume 12, Issue 1, pp. 1 - 5
The hippocampus has been known to process temporal information as part of memory formation. While time cells have been observed in the hippocampus and medial... 
Space | In vivo calcium imaging | SEQUENCES | Memory | Time | BRIDGE | NEUROSCIENCES | TIME CELLS | ISLAND | Time cell | OCEAN CELLS | Entorhinal cortex | Temporal discrimination | Timing | Hippocampus
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2018, Volume 82, Issue 4, pp. 649 - 654
Angiogenesis plays a crucial role in the development, growth, and metastasis of carcinomas, and studies have reported conflicting evidence regarding the VEGFR... 
Thyroid cancer | Medicine & Public Health | Oncology | Cancer Research | Clinical research | Lenvatinib | Pharmacology/Toxicology | Molecular biology | Vascular endothelial growth factor | FACTOR VEGF | VASCULOGENIC MIMICRY | ANGIOGENESIS | NEOPLASMS | FACTOR-C | TUMORS | ONCOLOGY | RELEVANCE | PHARMACOLOGY & PHARMACY | PAPILLARY | CARCINOMA | Immunohistochemistry | Humans | Male | Gene Expression Profiling | Antineoplastic Agents - administration & dosage | Quinolines - administration & dosage | Neovascularization, Pathologic - pathology | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Female | Cross-Sectional Studies | Thyroid Carcinoma, Anaplastic - drug therapy | Japan | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Treatment Outcome | Phenylurea Compounds - administration & dosage | Thyroid Neoplasms - drug therapy | Neovascularization, Pathologic - drug therapy | Thyroid Gland - pathology | Thyroid Carcinoma, Anaplastic - pathology | Aged | Cell Proliferation - drug effects | Biopsy, Large-Core Needle - methods | Quinolines - adverse effects | Thyroid Neoplasms - pathology | Medical research | Care and treatment | Cancer patients | Medicine, Experimental | Metastasis | Health aspects | Carcinoma | Males | Patients | Vascular endothelial growth factor receptors | Metastases | Proteins | Angiogenesis | Biopsy | Surgery | Females | Vascular endothelial growth factor receptor 2 | Tumors | Thyroid | Cancer
Journal Article
Journal Article
Journal Article
International Journal of Oncology, ISSN 1019-6439, 09/2008, Volume 33, Issue 3, pp. 525 - 532
Angiocenesis is mediated mainly by vascular endothelial growth factor (VEGF), and VEGF causes rapid growth in cancers, including human small-cell lung cancer... 
Microvessel counts | Anti-angiogenic therapy/strategy | VEGF receptor | Tyrosine kinase inhibitor | Small-cell lung cancer | Vascular endothelial growth factor | GEFITINIB | MALIGNANT-TUMORS | small-cell lung cancer | MONOCLONAL-ANTIBODY | TUMOR ANGIOGENESIS | ANTITUMOR-ACTIVITY | ZD6474 | EGFR | ANTIANGIOGENIC THERAPY | ONCOLOGY | vascular endothelial growth factor | RESISTANCE | anti-angiogenic therapy/strategy | microvessel counts | tyrosine kinase inhibitor | ENDOTHELIAL GROWTH-FACTOR | Lung Neoplasms - drug therapy | Vascular Endothelial Growth Factor A - biosynthesis | Carcinoma, Small Cell - blood supply | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Necrosis | Dose-Response Relationship, Drug | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Quinazolines - administration & dosage | Vascular Endothelial Growth Factor A - drug effects | Lung Neoplasms - blood supply | In Situ Nick-End Labeling | Piperidines - administration & dosage | Vascular Endothelial Growth Factor Receptor-2 - drug effects | Carcinoma, Small Cell - metabolism | Carcinoma, Small Cell - drug therapy | Reverse Transcriptase Polymerase Chain Reaction | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 08/2007, Volume 2, Issue 8, pp. S510 - S510
Journal Article
Diagnostic and therapeutic endoscopy, ISSN 1070-3608, 2001, Volume 7, Issue 3-4, pp. 187 - 195
To detect invisible lung cancer and to determine field of laser radiation during PDT we developed a full-color fluorescence fiberscopic system. We tested the... 
Journal Article
Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society, ISSN 1343-3490, 2003, Volume 41, Issue 2, pp. 112 - 116
Journal Article
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, ISSN 1343-3490, 02/2003, Volume 41, Issue 2, p. 112
A 49-year-old woman was referred to our hospital because abnormal masses had been found in the left lung on chest radiography. This examination and CT scanning... 
Hamartoma - pathology | Hemangioma - complications | Hemangioma - pathology | Humans | Middle Aged | Female | Lung Neoplasms - pathology | Lung Diseases - complications | Lung Diseases - pathology | Hamartoma - complications | Lung Neoplasms - complications
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.